 | • レポートコード：MRC2-11QY12208 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はホジキンリンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（アルキル化抗腫瘍剤、抗腫瘍性抗腫瘍剤、抗腫瘍剤ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗タボライト抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、コルチコステロイド）市場規模、用途別（病院、学術・研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ホジキンリンパ腫治療薬の競争状況、市場シェア ・世界のホジキンリンパ腫治療薬市場：種類別市場規模 2015年-2020年（アルキル化抗腫瘍剤、抗腫瘍性抗腫瘍剤、抗腫瘍剤ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗タボライト抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、コルチコステロイド） ・世界のホジキンリンパ腫治療薬市場：種類別市場規模予測 2021年-2026年（アルキル化抗腫瘍剤、抗腫瘍性抗腫瘍剤、抗腫瘍剤ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗タボライト抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、コルチコステロイド） ・世界のホジキンリンパ腫治療薬市場：用途別市場規模 2015年-2020年（病院、学術・研究機関） ・世界のホジキンリンパ腫治療薬市場：用途別市場規模予測 2021年-2026年（病院、学術・研究機関） ・北米のホジキンリンパ腫治療薬市場分析：米国、カナダ ・ヨーロッパのホジキンリンパ腫治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのホジキンリンパ腫治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のホジキンリンパ腫治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのホジキンリンパ腫治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol Myers Squibb、F. Hoffmann-La Roche、Merck、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hodgkin’s Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection. The main treatments used are chemotherapy, followed by radiotherapy or chemotherapy alone. Generally surgery is not used as a treatment for the condition.
The Hodgkin’s lymphoma therapeutics pipeline is expected to witness considerable growth in the coming years as the researchers are making novel drug delivery system for the treatment for cancer. The government agencies such as National Cancer Institute and American Cancer Society are supporting the growth of the Hodgkin’s lymphoma (HL) therapeutics pipeline by providing funding, designations and grants for speeding up the drug development process. High prevalence of cancer, increasing awareness regarding cancer treatment, technological advancements and high demand for safe and effective medication are driving the growth of the Hodgkin’s Lymphoma therapeutics pipeline.
Market Analysis and Insights: Global Hodgkin’s Lymphoma Therapeutics Market
The global Hodgkin’s Lymphoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hodgkin’s Lymphoma Therapeutics Scope and Market Size
Hodgkin’s Lymphoma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hodgkin’s Lymphoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol Myers Squibb
F. Hoffmann-La Roche
Merck
Pfizer
…
Market segment by Type, the product can be split into
Alkylating Antineoplastic Agents
Antibiotic Antineoplastic Agents
Antineoplastics Vinca Alkaloid Agents
Podophyllotoxin Derivative Antineoplastic Agents
Antimetabolite Antineoplastic Agents
Anthracycline Antineoplastic Agents
Antimicrotubular Antineoplastics
Corticosteroids
Market segment by Application, split into
Hospitals
Academic and Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hodgkin’s Lymphoma Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Hodgkin’s Lymphoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Alkylating Antineoplastic Agents
1.4.3 Antibiotic Antineoplastic Agents
1.4.4 Antineoplastics Vinca Alkaloid Agents
1.4.5 Podophyllotoxin Derivative Antineoplastic Agents
1.4.6 Antimetabolite Antineoplastic Agents
1.4.7 Anthracycline Antineoplastic Agents
1.4.8 Antimicrotubular Antineoplastics
1.4.9 Corticosteroids
1.5 Market by Application
1.5.1 Global Hodgkin’s Lymphoma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Academic and Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hodgkin’s Lymphoma Therapeutics Market Perspective (2015-2026)
2.2 Global Hodgkin’s Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Hodgkin’s Lymphoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hodgkin’s Lymphoma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Hodgkin’s Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hodgkin’s Lymphoma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Hodgkin’s Lymphoma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hodgkin’s Lymphoma Therapeutics Players by Market Size
3.1.1 Global Top Hodgkin’s Lymphoma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Hodgkin’s Lymphoma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Hodgkin’s Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hodgkin’s Lymphoma Therapeutics Market Concentration Ratio
3.2.1 Global Hodgkin’s Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hodgkin’s Lymphoma Therapeutics Revenue in 2019
3.3 Hodgkin’s Lymphoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Hodgkin’s Lymphoma Therapeutics Product Solution and Service
3.5 Date of Enter into Hodgkin’s Lymphoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hodgkin’s Lymphoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Hodgkin’s Lymphoma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Hodgkin’s Lymphoma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hodgkin’s Lymphoma Therapeutics Market Size (2015-2020)
6.2 Hodgkin’s Lymphoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hodgkin’s Lymphoma Therapeutics Market Size (2015-2020)
7.2 Hodgkin’s Lymphoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Hodgkin’s Lymphoma Therapeutics Market Size (2015-2020)
8.2 Hodgkin’s Lymphoma Therapeutics Key Players in China (2019-2020)
8.3 China Hodgkin’s Lymphoma Therapeutics Market Size by Type (2015-2020)
8.4 China Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hodgkin’s Lymphoma Therapeutics Market Size (2015-2020)
9.2 Hodgkin’s Lymphoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Hodgkin’s Lymphoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hodgkin’s Lymphoma Therapeutics Market Size (2015-2020)
10.2 Hodgkin’s Lymphoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hodgkin’s Lymphoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Hodgkin’s Lymphoma Therapeutics Market Size (2015-2020)
11.2 Hodgkin’s Lymphoma Therapeutics Key Players in India (2019-2020)
11.3 India Hodgkin’s Lymphoma Therapeutics Market Size by Type (2015-2020)
11.4 India Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hodgkin’s Lymphoma Therapeutics Market Size (2015-2020)
12.2 Hodgkin’s Lymphoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Hodgkin’s Lymphoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Hodgkin’s Lymphoma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Details
13.1.2 Bristol Myers Squibb Business Overview
13.1.3 Bristol Myers Squibb Hodgkin’s Lymphoma Therapeutics Introduction
13.1.4 Bristol Myers Squibb Revenue in Hodgkin’s Lymphoma Therapeutics Business (2015-2020))
13.1.5 Bristol Myers Squibb Recent Development
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Details
13.2.2 F. Hoffmann-La Roche Business Overview
13.2.3 F. Hoffmann-La Roche Hodgkin’s Lymphoma Therapeutics Introduction
13.2.4 F. Hoffmann-La Roche Revenue in Hodgkin’s Lymphoma Therapeutics Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Hodgkin’s Lymphoma Therapeutics Introduction
13.3.4 Merck Revenue in Hodgkin’s Lymphoma Therapeutics Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Hodgkin’s Lymphoma Therapeutics Introduction
13.4.4 Pfizer Revenue in Hodgkin’s Lymphoma Therapeutics Business (2015-2020)
13.4.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hodgkin's Lymphoma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Hodgkin's Lymphoma Therapeutics Revenue
Table 3. Ranking of Global Top Hodgkin's Lymphoma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hodgkin's Lymphoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Alkylating Antineoplastic Agents
Table 6. Key Players of Antibiotic Antineoplastic Agents
Table 7. Key Players of Antineoplastics Vinca Alkaloid Agents
Table 8. Key Players of Podophyllotoxin Derivative Antineoplastic Agents
Table 9. Key Players of Antimetabolite Antineoplastic Agents
Table 10. Key Players of Anthracycline Antineoplastic Agents
Table 11. Key Players of Antimicrotubular Antineoplastics
Table 12. Key Players of Corticosteroids
Table 13. Global Hodgkin's Lymphoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Hodgkin's Lymphoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Hodgkin's Lymphoma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Hodgkin's Lymphoma Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Hodgkin's Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Hodgkin's Lymphoma Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Hodgkin's Lymphoma Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Hodgkin's Lymphoma Therapeutics Players
Table 24. Global Hodgkin's Lymphoma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Hodgkin's Lymphoma Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Hodgkin's Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hodgkin's Lymphoma Therapeutics as of 2019)
Table 27. Global Hodgkin's Lymphoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Hodgkin's Lymphoma Therapeutics Product Solution and Service
Table 30. Date of Enter into Hodgkin's Lymphoma Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Hodgkin's Lymphoma Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Hodgkin's Lymphoma Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Hodgkin's Lymphoma Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Hodgkin's Lymphoma Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Hodgkin's Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Hodgkin's Lymphoma Therapeutics Market Share (2019-2020)
Table 40. North America Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Hodgkin's Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 42. North America Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Hodgkin's Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Hodgkin's Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Hodgkin's Lymphoma Therapeutics Market Share (2019-2020)
Table 46. Europe Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Hodgkin's Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Hodgkin's Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Hodgkin's Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Hodgkin's Lymphoma Therapeutics Market Share (2019-2020)
Table 52. China Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Hodgkin's Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 54. China Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Hodgkin's Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Hodgkin's Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Hodgkin's Lymphoma Therapeutics Market Share (2019-2020)
Table 58. Japan Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Hodgkin's Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Hodgkin's Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Hodgkin's Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Hodgkin's Lymphoma Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Hodgkin's Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Hodgkin's Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Hodgkin's Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Hodgkin's Lymphoma Therapeutics Market Share (2019-2020)
Table 70. India Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Hodgkin's Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 72. India Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Hodgkin's Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Hodgkin's Lymphoma Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Hodgkin's Lymphoma Therapeutics Market Share (2019-2020)
Table 76. Central & South America Hodgkin's Lymphoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Hodgkin's Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Hodgkin's Lymphoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Hodgkin's Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 80. Bristol Myers Squibb Company Details
Table 81. Bristol Myers Squibb Business Overview
Table 82. Bristol Myers Squibb Product
Table 83. Bristol Myers Squibb Revenue in Hodgkin's Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 84. Bristol Myers Squibb Recent Development
Table 85. F. Hoffmann-La Roche Company Details
Table 86. F. Hoffmann-La Roche Business Overview
Table 87. F. Hoffmann-La Roche Product
Table 88. F. Hoffmann-La Roche Revenue in Hodgkin's Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 89. F. Hoffmann-La Roche Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Hodgkin's Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Product
Table 98. Pfizer Revenue in Hodgkin's Lymphoma Therapeutics Business (2015-2020) (Million US$)
Table 99. Pfizer Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hodgkin's Lymphoma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Alkylating Antineoplastic Agents Features
Figure 3. Antibiotic Antineoplastic Agents Features
Figure 4. Antineoplastics Vinca Alkaloid Agents Features
Figure 5. Podophyllotoxin Derivative Antineoplastic Agents Features
Figure 6. Antimetabolite Antineoplastic Agents Features
Figure 7. Anthracycline Antineoplastic Agents Features
Figure 8. Antimicrotubular Antineoplastics Features
Figure 9. Corticosteroids Features
Figure 10. Global Hodgkin's Lymphoma Therapeutics Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Academic and Research Institutes Case Studies
Figure 13. Hodgkin's Lymphoma Therapeutics Report Years Considered
Figure 14. Global Hodgkin's Lymphoma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Hodgkin's Lymphoma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 16. Global Hodgkin's Lymphoma Therapeutics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Hodgkin's Lymphoma Therapeutics Market Share by Players in 2019
Figure 19. Global Top Hodgkin's Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hodgkin's Lymphoma Therapeutics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Hodgkin's Lymphoma Therapeutics Revenue in 2019
Figure 21. North America Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Hodgkin's Lymphoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
非ホジキンリンパ腫（NHL）の世界市場（～2026年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…- マイクロバブル/超音波造影剤の世界市場（～2026年） Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging a…
- 帯電防止剤の世界市場（～2026年） Market Analysis and Insights: Global Antistatic Agents Market The global Antistatic Agents market size is projected to reach US$ 359.5 million by 2026, from US$ 346.9 million in 2020, at a CAGR of 3.3%% during 2021-2026. Global Antistatic Agents Scope and Market Size Antistatic Agents market is segm…
- 局所止血剤の世界市場（～2026年） Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the l…
- 多発性硬化症治療薬の世界市場（～2026年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…